Previous Page  6 / 18 Next Page
Information
Show Menu
Previous Page 6 / 18 Next Page
Page Background

Page 48

Notes:

allied

academies

J Parasit Dis Diagn Ther 2017 | Volume 2 Issue 4

International Conference on

Zoology, Microbiology & Medical Parasitology

October 30-November 01, 2017 | Chicago, USA

Thalidomide affects macrophage activation and Leshmania

Z Zhanzak

1

and

Y.Goto

2

1

Nazarbayev University, Kazakhistan

2

University of Tokyo, Kazakhistan

Keywords:

Leishmaniasis, thalidomide, macrophage

activation, cytokines

Introduction:

Leishmania parasites are the causative agents

of LEISHMANIASIS, group of vector-borne parasitic diseases

endemic worldwide. Once inoculated into the organism,

Leishmania parasites are rapidly uptaken by macrophages.

Macrophages areprimary resident cells for their proliferation:

they can either phagocyte or allow parasite growth. That is

why proper activation of macrophages is crucial in disease

fate. Macrophage activation is divided into two classes:

classical (M1) and alternative (M2) that induce parasite

killing and its survival, respectively. Classical activation

is mediated by pro-inflammatory cytokines which cause

macrophages to produce toxic molecules to kill intracellular

parasites. In contrast, alternative activation is induced by

anti-inflammatory cytokines that lead to parasite survival in

infected cells. Thalidomide is reported to stimulate immune

response and enhance cellular phagocytotic activity by

selectively inhibiting M2 pathway. Here, thalidomide was

examined as potential drug to have suppressive effect

on intracellular replication of L.major within infected

macrophages in-vitro.

Methods:

To observe macrophage activation, Raw264.7 cells

were cultured. After 24hr incubation of cells in 370

0

C, 5% CO

2

incubator, thalidomide treatment of different concentration

was done. Supernatant and pellet were collected for ELISA,

RT-PCR, qPCR and WB tests. To observe pathogen survival,

Raw 264.7 cells were cultured in chamber slides and infected

with L. major at 1:10 ratio. After 24hr incubation, thalidomide

treatment was done. Giemsa staining was applied to slides

and intracellular amastigote forms of L.major were counted.

Results:

In this study thalidomide’s effect on proper

macrophage activation and parasite survival was analyzed.

It was found that thalidomide can a) up-regulate pro-

inflammatory M1 macrophages (IFN-γ, TNF-α, iNOS); b)

down-regulate anti-inflammatory M2 macrophages (IL-

10 and Arg-1); c) decrease intracellular amastigotes of L.

major. Thalidomide shows inhibitory effect on alternative

activation of macrophages and induces M1 polarization

of macrophages, thus making them resistant to L. major

infection.

Conclusion:

Results highlight thalidomide’s potential

contribution to a new drug development towards

Leishmaniasis in the future.

Speaker Biography

Z Zhanzak is an undergraduate student in School of Science and Technology, Nazarbayev

University,Kazakhistan.

e:

zhuldyZ

Zhanzak@nu.edu.kz